Xiao Q. Wang

21 Sassoon Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells.

An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells.

Journal: Nature protocols
Published: December 23, 2022

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.

Journal: Cancers
Published: July 10, 2020

The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B.

The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B.

Journal: Cancers
Published: May 18, 2020

Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.

Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.

Journal: Cancers
Published: July 23, 2019

Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma.

Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma.

Journal: Oncotarget
Published: August 10, 2018

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma.

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma.

Journal: Theranostics
Published: February 10, 2018

Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.

Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.

Journal: Oncotarget
Published: August 06, 2017

Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.

Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.

Journal: PloS one
Published: February 24, 2017

Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.

Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.

Journal: Molecular cancer therapeutics
Published: January 03, 2017

Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.

Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.

Journal: Oncotarget
Published: November 02, 2016

Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.

Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.

Journal: Oral oncology
Published: October 13, 2016

XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.

XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.

Journal: BMC cancer
Published: September 21, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026